Skip to main content

COVID-19: Prevention, Treatment and Vaccines

The medications listed below are related to or used in the treatment of this condition.

Filter
Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
nirmatrelvir / ritonavir 7.1 502 reviews for nirmatrelvir / ritonavir to treat COVID-19
Rx N
Generic name:
nirmatrelvir / ritonavir systemic
Brand name:
Paxlovid
Drug class:
antiviral combinations
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Paxlovid 7.1 494 reviews for Paxlovid to treat COVID-19
Rx N
Generic name:
nirmatrelvir / ritonavir systemic
Drug class:
antiviral combinations
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
molnupiravir EUA 6.8 41 reviews for molnupiravir to treat COVID-19
Rx N
Generic name:
molnupiravir systemic
Brand name:
Lagevrio
Drug class:
miscellaneous antivirals
For consumers:
dosage, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Emergency Use Authorization:
Yes
remdesivir 5.1 38 reviews for remdesivir to treat COVID-19
Rx N X
Generic name:
remdesivir systemic
Brand name:
Veklury
Drug class:
purine nucleosides
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
sars-cov-2 (covid-19) mrna-1273 vaccine Off-label EUA 5.0 30 reviews for sars-cov-2 (covid-19) mrna-1273 vaccine to treat COVID-19
Rx N
Generic name:
sars-cov-2 (covid-19) mrna-1273 vaccine systemic
Drug class:
viral vaccines
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Off-label:
Yes
Emergency Use Authorization:
Yes
ivermectin Off-label 7.8 21 reviews for ivermectin to treat COVID-19
Rx C N X
Generic name:
ivermectin systemic
Drug class:
anthelmintics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes
Pfizer-BioNTech COVID-19 Vaccine 6.9 16 reviews for Pfizer-BioNTech COVID-19 Vaccine to treat COVID-19
Rx N
Generic name:
sars-cov-2 mrna (tozinameran) vaccine
Drug class:
viral vaccines
For consumers:
dosage, interactions, side effects
sars-cov-2 mrna (tozinameran) vaccine 6.9 16 reviews for sars-cov-2 mrna (tozinameran) vaccine to treat COVID-19
Rx N
Generic name:
sars-cov-2 mrna (tozinameran) vaccine
Brand names:
Pfizer-BioNTech COVID-19 Vaccine, Comirnaty
Drug class:
viral vaccines
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Lagevrio EUA 8.2 9 reviews for Lagevrio to treat COVID-19
Rx N
Generic name:
molnupiravir systemic
Drug class:
miscellaneous antivirals
For consumers:
dosage, side effects
Emergency Use Authorization:
Yes
bebtelovimab Off-label 3.5 4 reviews for bebtelovimab to treat COVID-19
Rx N
Generic name:
bebtelovimab systemic
Drug class:
miscellaneous antivirals
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes
baricitinib 1.0 2 reviews for baricitinib to treat COVID-19
Rx N
Generic name:
baricitinib systemic
Brand name:
Olumiant
Drug class:
antirheumatics, selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Olumiant 1.0 2 reviews for Olumiant to treat COVID-19
Rx N
Generic name:
baricitinib systemic
Drug class:
antirheumatics, selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
REGEN-COV 5.5 2 reviews for REGEN-COV to treat COVID-19
Rx N
Generic name:
casirivimab / imdevimab systemic
Drug class:
antiviral combinations
For consumers:
dosage, interactions,
For professionals:
AHFS DI Monograph, Prescribing Information
bamlanivimab / etesevimab EUA 1.0 1 review for bamlanivimab / etesevimab to treat COVID-19
Rx U
Generic name:
bamlanivimab / etesevimab systemic
Brand name:
bamlanivimab and etesevimab
For consumers:
For professionals:
Prescribing Information
Emergency Use Authorization:
Yes
bamlanivimab and etesevimab EUA 1.0 1 review for bamlanivimab and etesevimab to treat COVID-19
Rx U
Generic name:
bamlanivimab / etesevimab systemic
For consumers:
For professionals:
AHFS DI Monograph
Emergency Use Authorization:
Yes
Gohibic EUA 10 1 review for Gohibic to treat COVID-19
Rx N
Generic name:
vilobelimab systemic
Drug class:
miscellaneous antivirals
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Emergency Use Authorization:
Yes
Novavax COVID-19 Vaccine EUA 0.0 1 review for Novavax COVID-19 Vaccine to treat COVID-19
Rx N
Generic name:
sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant systemic
For consumers:
dosage, interactions, side effects
Emergency Use Authorization:
Yes
sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant EUA 0.0 1 review for sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant to treat COVID-19
Rx N
Generic name:
sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant systemic
Brand name:
Novavax COVID-19 Vaccine
Drug class:
viral vaccines
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Emergency Use Authorization:
Yes
vilobelimab EUA 10 1 review for vilobelimab to treat COVID-19
Rx N
Generic name:
vilobelimab systemic
Brand name:
Gohibic
Drug class:
miscellaneous antivirals
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Emergency Use Authorization:
Yes
Actemra Rate Add review
Rx C N
Generic name:
tocilizumab systemic
Drug class:
interleukin inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
anakinra EUA Rate Add review
Rx B N
Generic name:
anakinra systemic
Brand name:
Kineret
Drug class:
antirheumatics, interleukin inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Emergency Use Authorization:
Yes
Comirnaty Rate Add review
Rx N
Generic name:
sars-cov-2 mrna (tozinameran) vaccine
Drug class:
viral vaccines
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Comirnaty (2023-2024) PF (cvx 309) Rate Add review
Rx N
Generic name:
sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309) systemic
Drug class:
viral vaccines
For consumers:
dosage, interactions, side effects
Kineret EUA Rate Add review
Rx B N
Generic name:
anakinra systemic
Drug class:
antirheumatics, interleukin inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Emergency Use Authorization:
Yes
Moderna COVID-19 (2023-2024) PF Vaccine (cvx 311) EUA Rate Add review
Rx N
Generic name:
sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 311) systemic
Drug class:
viral vaccines
For consumers:
dosage, interactions, side effects
Emergency Use Authorization:
Yes

Frequently asked questions

View more FAQ

Drugs in development for the treatment of COVID-19

Learn more about COVID-19

Care guides

Medicine.com guides (external)

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.